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It is a damning indictment of surgery that, despite our reliance on complex interventions,
many aspects of our practice in all specialties including Oral and Maxillofacial Surgery
(OMFS), are not evidence based.
In 2000, the UK Medical Research Council set out clear guidance for the assessment of
complex interventions.1 Almost a decade later, in 2009, McCulloch et al.2 gave
recommendations in the Lancet for assessing surgery. This was based on a five-stage
description of the surgical development process, including the initial idea, followed by
development, exploration, assessment, and long-term study (the IDEAL framework).
In the UK, there is limited funding for research into surgical innovations, and unlike the
pharmaceutical industry, technology developers do not have to follow strict regulatory
frameworks. Consequently, novel devices can make their way to operating theatres in the
hands of innovative surgeons and can become standard practice without having a peer-
reviewed evidence base. Moreover, these innovators may have worse initial outcomes
because of the learning curve when starting to use the device, and these outcomes rarely find
their way into the literature3.
In contrast to these innovators, there are also surgeons who continue to use established
techniques or management protocols with which they are comfortable. They may continue to
achieve acceptable outcomes (however these are defined), and who pass their approach
unchanged to new generations of trainees3.
In the UK, we have many great centres with diverse expertise. Unfortunately, all too often
they work in isolation. We are a small specialty in challenging times. Most National Health
Service surgeons are under pressure and need to be supported to participate in research. This
help needs to be practical with trial design and recruitment so that they can evaluate the
safety and efficacy of novel and established techniques. The support should also be pragmatic
and derived from surgical colleges, editors, and key stakeholders such as the National
Institute for Health Research (NIHR).
The way forward is not simply to work harder with the resources we have: this will only lead
to failure and disappointment. As surgeons, we need to know what is available to us if we are
to appreciate the benefits of innovation in our daily practice.
 OMFS needs a better infrastructure and a change in culture among surgeons, educators and
managers. We need to embrace and support trials, we need to be active in seeking principal
investigator duties, we need to support workshops and make better use of the research design
resources available in our local trials units. Participation in organised research networks can
help us build expertise and infrastructure in local units.
It is unlikely that most hospitals will have access to additional central resources and therefore
additional manpower may be funded by recruiting patients to portfolio studies. We should
encourage national collaborations, a register of innovations, and approval from ethics
committees.
Finally, we must find ways to develop a culture of research and innovation during speciality
training. The requirements to publish and learn by “going through the process” have almost
vanished. Why not include training in Good Clinical Practice for trials and taught critical
reading skills as a prerequisite for the Certificate of Completion of Specialist Training? In
particular, training programme directors should encourage trainee-led collaborative
multicentre research, and we should learn from successful OMFS collaboratives.
It is time to simultaneously empower and regulate innovation in OMFS, but this can only be
done if we actively participate in research and clinical trials. Only then can we take the
specialty into the new era that it so desperately needs.
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